|
Recent Developments |
|
08-DEC-11
Brooks Laboratories has received approval for manufacture of Doripenem Monohydrate Injection from Directorate General of Health Service. The company is all set to manufacture this drug within this fiscal year.
Future Plans
The company now plans to set up a new manufacturing unit at Panoli, Gujarat for manufacturing formulations with an investment of Rs 520 million. Also, Rs 50 million from IPO proceeds will be utilized towards lon... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2017(6) | 31-Mar-2017(12) | 31-Mar-2016(12) | | Net sales | 215.13 | 623.04 | 800.09 | | Other Income | 0.99 | 1.62 | 15.62 | | Total Income | 216.12 | 624.66 | 815.71 | | Cost of goods sold | 281.18 | 577.20 | 689.24 | | OPBDIT | -65.06 | 47.46 | 126.47 | | PAT | -88.99 | 19.56 | 106.35 | | Gross Block | - | - | - | | Equity capital | - | - | 161.86 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | -30.1 | 7.6 | 15.5 | | Net margin (% of OI) | -41.2 | 3.1 | 13.0 |
|
|
Detailed Financials
|
|
|
|
|
